author-photo

Andrew J. Carroll

University of Alabama at Birmingham
University of Alabama
Pediatric Oncology Group

467

Papers

32128

Citations

Citation Trend

Filter By

Papers (465) Sort By

Journal Conference Others

FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631.

2021 Leukemia
Show All
- Source
- Cite
- Save
Citations (3)
Molecular associations, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia (Alliance).

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
VpreB Surrogate Light Chain Expression in B-Lineage ALL: A Report from the Children's Oncology Group.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
Multi-Dimensional Analysis of Adult Acute Myeloid Leukemia (AML) Landscape Cross-Continents Reveals Age Associated Trends in Mutations and Outcomes

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
White Blood Cell Count (WBC) Levels Are Associated with Molecular Profiles and Are Independent Outcome Predictors in Acute Myeloid Leukemia (AML) Patients (Pts) (Alliance)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance).

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (1)
Establishment and genomic characterization of a sporadic malignant peripheral nerve sheath tumor cell line.

2021 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (0)
Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (2)
Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia.

2021 Haematologica
Show All
- Source
- Cite
- Save
Citations (0)
Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's Oncology Group Study AALL0232.

2021 Leukemia
Show All
- Source
- Cite
- Save
Citations (0)